Management Team

LEAH MAKLEY

CHIEF SCIENTIFIC OFFICER

Leah received a Ph.D. in medicinal chemistry from the University of Michigan in 2014, and a B.S. in biochemistry from the University of Dayton in 2009. She developed ViewPoint's flagship technology as a graduate student in Jason's lab and cofounded the company. While at the University of Michigan, she participated in the Pharmacological Sciences Training Program, was a fellow of the American Foundation for Pharmaceutical Education, and was named an Alzheimer's Drug Discovery Foundation Young Investigator. Leah has expertise in biophysical methods, protein biochemistry, high-throughput screening, and medicinal chemistry. 

YEVGENIY IZRAYELIT

Director of chemical biology

Yevgeniy received a Ph.D. in chemical biology at Cornell University in 2014, and a B.A. in biochemistry from Vassar College in 2006. During his time at Cornell working in Frank Schroeder’s laboratory, Yevgeniy was a participant in the NIH Chemistry Biology Interface Training Grant and contributed to seven peer-reviewed publications. His research and teaching efforts were recognized by the Bayer Teaching Excellence Award, the Vassar College Mary Landon Sague Fellowship, the Proctor & Gamble Cornell Graduate Student Best Paper Award, and the Tunis Wentink Prize for outstanding academic and research performance. Yevgeniy received additional training as a graduate summer intern at Pfizer’s Cardiovascular and Metabolic Diseases Research Unit working with Kay Ahn, Ph.D. and as a visiting scientist in the lab of Jake Bundy, Ph.D at Imperial College London. Prior to joining ViewPoint, Yevgeniy spent a year as a postdoctoral fellow in the Center for Biomedical Engineering at Brown University working in the Wong Lab. Yevgeniy’s multidisciplinary expertise includes chemical biology, analytical chemistry, drug discovery, and small molecule signaling.

ViewPoint is further supported by a team of consultants and contractors with deep expertise in Medicinal Chemistry, Ophthalmic formulations, preclinical and clinical development, chemistry manufacturing, and regulatory affairs.